Synaptogenix Inc

NASDAQ:SNPX   11:47:19 AM EDT
4.50
-0.16 (-3.43%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Synaptogenix Inc Stock, NASDAQ:SNPX

1185 Avenue of the Americas, 3rd floor, New York, New York 10036
United States of America
Phone: +1.973.242.0005
Number of Employees: 8
http://www.synaptogen.com

Description

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer�s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson�s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.